WallStreetZenWallStreetZen

NASDAQ: AKBA
Akebia Therapeutics Inc Stock Ownership - Who owns Akebia Therapeutics?

Insider buying vs selling

Have Akebia Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Nicole R. HadasSVP Chief Legal Officer2024-05-1312,016$1.26
$15.14kSell
Michel DahanSVP Chief Operating Officer2024-05-1334,840$1.26
$43.90kSell
Nicole R. HadasSVP Chief Legal Officer2024-02-295,974$1.58
$9.44kSell
Steven Keith BurkeSVP Chief Medical Officer2024-02-297,169$1.58
$11.33kSell
John P. ButlerCEO and President2024-02-2946,570$1.58
$73.58kSell
Michel DahanSVP Chief Operating Officer2024-02-298,661$1.58
$13.68kSell
Steven Keith BurkeSVP Chief Medical Officer2024-02-278,367$1.52
$12.72kSell
Michel DahanSVP Chief Operating Officer2024-02-2710,744$1.52
$16.33kSell
Nicole R. HadasSVP Chief Legal Officer2024-02-277,411$1.52
$11.26kSell
John P. ButlerCEO and President2024-02-2737,733$1.52
$57.35kSell

1 of 2

AKBA insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when AKBA insiders and whales buy or sell their stock.

AKBA Shareholders

What type of owners hold Akebia Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Alerce Investment Management LP6.30%13,205,119$15.19MInstitution
Vanguard Group Inc3.92%8,225,972$9.46MInstitution
Acadian Asset Management LLC2.53%5,309,755$6.11MInstitution
Muneer A. Satter2.40%5,039,602$5.80MInsider
Renaissance Technologies LLC1.74%3,652,100$4.20MInstitution
Novartis Bioventures Ltd1.62%3,405,764$3.92MInsider
Millennium Management LLC1.56%3,266,000$3.76MInstitution
John P. Butler1.40%2,942,080$3.38MInsider
Blackrock Inc1.21%2,539,225$2.92MInstitution
Qube Research Technologies Ltd1.08%2,262,676$2.60MInstitution

1 of 3

AKBA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
AKBA27.21%8.82%Net SellingNet Selling
ELYM57.94%22.46%Net Buying
CHRS71.14%18.37%Net Buying
QURE66.45%13.78%Net SellingNet Selling
GBIO64.26%35.74%Net BuyingNet Selling

Akebia Therapeutics Stock Ownership FAQ

Who owns Akebia Therapeutics?

Akebia Therapeutics (NASDAQ: AKBA) is owned by 27.21% institutional shareholders, 8.82% Akebia Therapeutics insiders, and 63.97% retail investors. Muneer A. Satter is the largest individual Akebia Therapeutics shareholder, owning 5.04M shares representing 2.40% of the company. Muneer A. Satter's Akebia Therapeutics shares are currently valued at $5.80M.

If you're new to stock investing, here's how to buy Akebia Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.